The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Ivana Kumar; Anshita Kumari, MBBS; Kusum Lata, MD, FACC, FSCAI
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"The DETOUR System (Endologix) and percutaneous transmural arterial bypass (PTAB) represents a truly exciting addition to our armamentarium for the treatment of complex peripheral artery disease (PAD) patients," says Jaafar A. Golzar, MD,...
"The DETOUR System (Endologix) and percutaneous transmural arterial bypass (PTAB) represents a truly exciting addition to our armamentarium for the treatment of complex peripheral artery disease (PAD) patients," says Jaafar A. Golzar, MD,...
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute podcast, Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring shifts management from reactive to proactive by detecting hemodynamic congestion before clinical deterioration occurs.
In this 29-minute podcast, Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring shifts management from reactive to proactive by detecting hemodynamic congestion before clinical deterioration occurs.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
With a collaborative culture, high-volume expertise, and investment in cutting edge technology, Baystate Medical Center has become a nationally recognized leader in cardiovascular care. In the recent renovation and expansion of Baystate’s...
With a collaborative culture, high-volume expertise, and investment in cutting edge technology, Baystate Medical Center has become a nationally recognized leader in cardiovascular care. In the recent renovation and expansion of Baystate’s...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Manit Sabharwal ; Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Long-term radialists Morton Kern, MD, and Arnold Seto, MD, MPA, discuss a novel radial access tool, the Prelude Wave™, with Merit Medical®’s Manit Sabharwal. Discussion ranges from transradial access clinical tips to the challenges of...
Long-term radialists Morton Kern, MD, and Arnold Seto, MD, MPA, discuss a novel radial access tool, the Prelude Wave™, with Merit Medical®’s Manit Sabharwal. Discussion ranges from transradial access clinical tips to the challenges of...
In this video, Ryan K. Kaple, MD, FACC, FSCAI, discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this video, Ryan K. Kaple, MD, FACC, FSCAI, discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Ivana Kumar; Anshita Kumari, MBBS; Kusum Lata, MD, FACC, FSCAI
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
In his Nurses and Technologists presentation at CRT 2026, Dr. Hermiller describes how cath lab safety is improving, but only if teams treat radiation and orthopedic injury as daily, solvable problems.
In his Nurses and Technologists presentation at CRT 2026, Dr. Hermiller describes how cath lab safety is improving, but only if teams treat radiation and orthopedic injury as daily, solvable problems.
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
Brian C. Case, MD; Dionne P. Ross, MSN, RN, NE-BC; Allen Jeremias, MD, MSc; Bruce A. Samuels, MD; Arnold H. Seto, MD, MPA, FACC, FSCAI
Panelists at CRT 2026 share practical takeaways on angio FFR limits, low/zero-contrast PCI workflows, building coronary microvascular dysfunction (CMD) function-testing programs, and the impact of AI.
Panelists at CRT 2026 share practical takeaways on angio FFR limits, low/zero-contrast PCI workflows, building coronary microvascular dysfunction (CMD) function-testing programs, and the impact of AI.
Dr. Hofmeyer describes how HF therapy is pivoting from medication-only optimization to catheter-based and device-based strategies that increasingly intersect with interventional workflows.
Dr. Hofmeyer describes how HF therapy is pivoting from medication-only optimization to catheter-based and device-based strategies that increasingly intersect with interventional workflows.
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
Richard Casazza, MAS; Neel Patel, MD; Allan Mattia, MD; Paul Saunders, MD; Arsalan Hashmi, MD; Greg Ribakove, MD
Cardiac myxomas are histologically benign tumors; however, they may lead to life-threatening complications. The authors share the case of a successful removal of myxoma with resolution of the patient's symptoms.
Cardiac myxomas are histologically benign tumors; however, they may lead to life-threatening complications. The authors share the case of a successful removal of myxoma with resolution of the patient's symptoms.
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
